Biotechnology/Chemical/Pharmaceutical Customer Partnership
Tuesday, June 1, 2010
United States Patent and Trademark Office
600 Dulany Street, Alexandria, VA
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on March 2, 2010 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, June 1, 2010 from 10:00 am to 4:00 pm at Auditorium in Madison North, 600 Dulany Street, Alexandria, Virginia.
For information of future meetings and presentations, please go to http://www.cabic.com/bcp/.
Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by May 21, 2010.
Agenda & Schedule
|10:00-10:15||Greetings and Overview||George Elliott and Remy Yucel, Directors, Technology Center 1600|
|10:15-11:15||Reexam Best Practice||CRU|
|11:15 -11:40||Ombudsman||Valencia Martin-Wallace, Director, Technology Center 2400|
|11:15 - 12:40||Information Disclosure Statement||Julie Burke, QAS, TC1600|
12:40 - 1:50
|1:50 – 2:20||Restriction Form Paragraph||Julie Burke, QAS, TC1600|
|2:20 - 2:35||Break|
|2:35 -3:35||A Perspective on Gene Patents||Hans Sauer, Associate General Counsel for Intellectual Property, BIO|
|3:35 -3:50||Closing Remarks/Discussion||George Elliott and Remy Yucel, Directors, Technology Center 1600|
Accessing the event online
1. Navigate to https://uspto.connectsolutions.com/r83435533/
2. Select "Enter as a Guest" option.
3. External guests - please login using your email address
(USPTO Employees - please login using your last name, first name)
4. Click on the "Enter Room" button
5. You will be admitted to the meeting
If you need assistance with login, please contact Darcy Bates at (571) 272-2499 or Carrie Scott at (571) 272-2992